Fresh analysis reveals that individuals who come off new slimming jabs like Mounjaro or Wegovy can put back on lost weight far faster than those who stop traditional lifestyle regimens.
Research printed in a major medical journal demonstrates that while obese people frequently drop a large proportion of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.
"People using these drugs need to be aware of the potential of rapid weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
Such speed of recovery suggests a return to pre-treatment mass in about a year and a half.
Weighing Approaches
The research, which looked at 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.
The team emphasize that people who shed pounds through dieting usually see a slower weight regain—approximately 0.1 kg a month—after stopping.
Understanding the Quick Regain
Nutrition scientists suggest the way of the drugs explains the amplified rebound.
GLP-1 drugs imitate a natural hormone called GLP-1, which helps regulate hunger.
"Sustained high doses of the hormone concentrations far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating a significant risk."
A Chronic Disease?
Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of weight regain, the treatment should be considered ongoing.
This perspective is echoed by pharmaceutical companies, who state that the findings "underscore the chronic nature of obesity," similar to managing conditions like diabetes.
User Accounts
Users who have discontinued the jabs describe a sudden return of cravings.
"It felt as if a trigger that goes on and I was suddenly extremely hungry," said an individual.
This difficulty is exacerbated if patients have not established lasting lifestyle or habit modifications during treatment.
Growing Adoption
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest being substantial.
- Adoption is greater among females than men.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, experts emphasize that while the jabs are potent agents for weight loss, they are not a magic cure and maintained weight loss hinges on ongoing lifestyle changes.
